Myhibbin 200 mg/mL oral suspension Images
Generic Name: mycophenolate mofetil
This medication has been identified as Myhibbin 200 mg/mL oral suspension. It is supplied by Azurity Pharmaceuticals, Inc.
Myhibbin is used in the treatment of Organ Transplant, Rejection Prophylaxis. There is positive evidence of human fetal risk during pregnancy. Myhibbin 200 mg/mL oral suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Myhibbin
- Generic Name
- mycophenolate mofetil
- Strength
- 200 mg/mL oral suspension
- Availability
- Prescription only
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Azurity Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 24338-0018
More about Myhibbin (mycophenolate mofetil)
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
